Bio‑Rad Laboratories jumps after report Elliott builds stake

Bio-Rad Laboratories

18/05/2026 11:39

** Shares of U.S. diagnostics supplier Bio-Rad Laboratories BIO.N up 7% at $265.01 premarket

** The Wall Street Journal reports activist investor Elliott Investment Management has built a sizeable stake in co

** Elliott plans to push the company to boost its underperforming stock price - WSJ

** Report also says Elliott has built a stake in German biopharma equipment supplier Sartorius SATG.DE, in which Bio‑Rad is an investor

** Exact size of Elliott’s stakes in Bio‑Rad or Sartorius is not disclosed in the report

** Reuters could not immediately verify the report; Elliott, Bio‑Rad and Sartorius did not respond to requests for comment

** As of last close, BIO stock down 18.3% YTD

 (Reporting by Tharuniyaa Lakshmi in Bengaluru)

 ((tharuniyaa@thomsonreuters.com))